Fox Chase Cancer Center Welcomes Dylan R. Sherry

Dr. Sherry will be joining the Pain and Palliative Care Program in the Department of Hematology/Oncology as an assistant professor.
Dr. Sherry will be joining the Pain and Palliative Care Program in the Department of Hematology/Oncology as an assistant professor.

PHILADELPHIA (December 30, 2019) – Fox Chase Cancer Center announces the hiring of Dylan R. Sherry, MD, who will be joining the Pain and Palliative Care Program in the Department of Hematology/Oncology as an assistant professor on the academic clinician track.

Sherry comes to Fox Chase from Abington Memorial Hospital, where he was working as a hospitalist. Sherry is board certified in internal medicine and board eligible in hospice and palliative medicine.

He received both his medical degree and a master’s degree in bioethics from Case Western Reserve University School of Medicine in Cleveland. Sherry completed his Internal Medicine Residency and Hospice and Palliative Medicine Fellowship at Beth Israel Deaconess Medical Center in Boston, graduating from fellowship in June 2019. During his time there he was an Internal Medicine House Staff Council Member and later a co-chair of the Internal Medicine House Staff Council.

Sherry will begin work at Fox Chase on January 1, 2020.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text